Ivacaftor

CAS 873054-44-5

Overview

Ivacaftor is a drug used to treat cystic fibrosis in people with certain mutations in the cystic fibrosis transmembrane conductance regulator gene, who account for 4–5% cases of cystic fibrosis

Anant Labs manufacture and furnish high quality Ivacaftor impurities for global markets. Our Ivacaftor EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

In Stock

Ivacaftor

Cat. No. ANTPRD7364Old No. ANT-IVC-000CAS 873054-44-5In Stock

Technical Data

New Cat. No.ANTPRD7364

Old Cat. No.ANT-IVC-000

CAS873054-44-5

Mol. FormulaC₂₄H₂₈N₂O₃

Mol. Weight392.49 g/mol

IUPACN-(2,4-ditert-butyl-5-hydroxyphenyl)-4-oxo-1H-quinoline-3-carboxamide

SMILESCC(C)(C)C1=CC(=C(C=C1NC(=O)C2=CNC3=CC=CC=C3C2=O)O)C(C)(C)C

InChIInChI=1S/C24H28N2O3/c1-23(2,3)16-11-17(24(4,5)6)20(27)12-19(16)26-22(29)15-13-25-18-10-8-7-9-14(18)21(15)28/h7-13,27H,1-6H3,(H,25,28)(H,26,29)

InChI KeyPURKAOJPTOLRMP-UHFFFAOYSA-N

Synonyms

N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamideIvacaftor873054-44-5VX-770Kalydecoivacaftorum1Y740ILL1ZCHEBI:66901DTXSID00236281ORKAMBI COMPONENT IVACAFTOR